Impact of alogliptin on coronary flow reserve evaluated by magnetic resonance imaging
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Alogliptin (Primary) ; Glimepiride
- Indications Angina pectoris; Coronary artery disease; Myocardial infarction; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 18 Nov 2013 Status changed from recruiting to completed.
- 29 Jun 2012 New trial record